Indivior Pharmaceuticals Inc. Common Stock vs Sotera Health Company Common Stock — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.03B), while Sotera Health Company Common Stock trades at $17.68 (market cap $5.06B). The key difference: Sotera Health Company Common Stock is the larger of the two by market cap, and Sotera Health Company Common Stock is trading nearer its 52-week high, Indivior Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Sotera Health Company Common Stock for 0 Days on average.
| INDV | SHC | |
|---|---|---|
Market Cap | $4.03B | $5.06B |
Volume | 2,781,171 | 2,279,715 |
Sector | Health | Health |
52-Week High | $41.83 | $19.57 |
52-Week Low | $24.09 | $13.13 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.32B | $6.97B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →Sotera Health Company is a US provider of sterilization and lab testing services for the healthcare industry, operating through its Sterigenics, Nordion, and Nelson Labs businesses.
Read more on SHC →